Lymphoma attacks the lymphatic system, specifically the white blood cells. It can be slow-growing or aggressive and requires prompt treatment. Studies have established a clear link between lymphoma and long-term exposure to ethylene oxide. Individuals living within 3 miles of these facilities emitting EtO face a considerably higher risk.
Claim ApplicationWhen inhaled, EtO is absorbed into the bloodstream and carried to the lymphoid tissues, where it acts as a DNA alkylating agent, binding directly to DNA without the need for prior metabolic activation. This causes the formation of DNA adducts, chromosomal damage, and mutations in lymphoid cells, which interfere with normal cell growth and lead to the transformation to cancer.
A case-control study involving over 2,300 lymphoma cases across six European countries found that medium-to-high frequency EtO exposure was associated with a 4.3-fold increase in lymphoma risk. Both the IARC and the EPA conclude that the strongest evidence linking EtO exposure to cancer involves lymphohematopoietic cancers, including lymphomas such as non-Hodgkin lymphoma and Hodgkin lymphoma, as well as leukemia and related blood cancers.
A large NIOSH cohort study also found increased mortality from lymphohematopoietic malignancies, including non-Hodgkin lymphoma, associated with high cumulative EtO exposure.
A lymphoma diagnosis brings physical, emotional, and financial strain, from ongoing treatment costs to time away from work. If your diagnosis is connected to EtO exposure, you may qualify for a claim and could be entitled to compensation from the facilities responsible.
Family members who have lost a loved one to an EtO-related lymphoma may also be eligible to file. We will assess whether you qualify and, if you do, handle the process of filing your EtO claim. Reach out to our legal team at ELG Law to have your case reviewed.
Monday – Friday
8:00 AM – 5:00 PM
Saturday & Sunday
Closed
